New Black Book Research survey reveals industry-wide concerns as tariffs on imports from Mexico, Canada, and China threaten ...
President Donald Trump on Saturday signed executive orders imposing sweeping tariffs on the country’s three largest trading ...
Majority of leaders in life sciences -- pharmaceutical and medical technology companies -- and high-tech companies like ...
7d
Vietnam Investment Review on MSNStimulating year ahead for pharmaVietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.
India Inc anticipates simplified tax laws, reduced litigation, and progressive policies in Budget 2025, with the ...
Everyday painkillers, antibiotics, cancer medications, blood thinners and more are just some of the drugs that the U.S.
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and ...
19h
GlobalData on MSNTrump’s tariffs will trickle down the clinical trial chainTrump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.
1d
StudyFinds on MSN95% of profits at major healthcare companies go to shareholders, not servicesUnveiling the truth about healthcare profits: 95% of net income goes to shareholders, not improving healthcare services or ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
The AHA asks President Trump to consider granting exceptions to the current and proposed tariffs for medical devices and pharmaceuticals made in Mexico, Canada and China that are essential to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results